Other
Journal
About P&T Journal
Contacts:Editor:
ssherritze@medimedia.com
Advertising:
mliberti@medimedia.com
Circulation:
lgardineer@medimedia.com
Production:
wpeart@medimedia.com
Rate Card
Production Specifications
Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints
Recent Issues
July 2008
Features
Drug Forecast
Posaconazole (Noxafil), an Extended-Spectrum Oral Triazole Antifungal Agent
Drs. Chang and Chagan review posaconazole (Noxafil) for fungal infections.
Mei Chang, BA, PharmD, and Larisa Chagan, PharmD, BCPS
Profile
FDA’s Janet Woodcock Riding High
An in-depth interview with the director of the FDA’s Center for Drug Evaluation and Research reveals a conscientious leader who is receiving high marks for her candor about the agency’s challenges.
Stephen Barlas
Meeting Highlights
American Society of Clinical Oncology
Presentations cover therapies for breast cancer, renal cell carcinoma, chronic myelogenous leukemia, non–small-cell lung cancer, bone resorption, and melanoma.
Walter Alexander
Continuing Education Credit
The Pharmacological Management of Migraine, Part 1
Migraine is the most common headache complaint in clinical practice. Part 1 of a two-part series presents a summary of treatments used to reduce the severity and duration of migraine and its associated symptoms and also discusses the comorbidities, clinical presentation, and risk factors associated with this affliction.
George DeMaagd, PharmD, BCPS
The Law of Unintended Consequences: When Pain Management Leads to Medication Errors
In 2001, The Joint Commission released new pain guidelines and attempted to address the problem of undertreated pain; however, the resulting focus on the pain score number has inadvertently led to some serious adverse drug events. In addition, the recent dramatic increase in opioid use has resulted in greater abuse of these prescribed drugs, often by teenagers.
Steven Hanks, MD, MMM, FACP
Departments
Editorial
Myth Busters
David Nash, MD, MBA, debunks four myths about health care spending. For instance, it is widely known that the U.S. spends more on health care than other nations, but this is not because of drug costs or doctor fees.
David B. Nash, MD, MBA
Medication Errors
Lowdown on Lomustine
Matthew Grissinger, RPh, FASCP, describes common mishaps that can occur with lomustine (CCNU), a drug used to treat Hodgkin’s disease and brain cancer.
Matthew Grissinger, RPh, FASCP
Prescription: Washington
Dollars Start to Flow to Doctors for E-prescribing Efforts
Stephen Barlas wonders whether offering money to doctors who switch to electronic prescriptions will be enough of an incentive.
Stephen Barlas
New Drugs/Drug News/New Medical Devices
From becaplermin to zoledronic acid, P&T presents the latest information about FDA approvals, new indications, recalls, and industry updates.
